Info
Dr. Rosalyn Juergens, McMaster Unievrsity, offers her perspective on the treatments emerging as showing the greatest promise as effective novel therapies for patients with lung cancer.
10 years ago
#antipd1, #antipdl1, #cancergrace, #grace, #gracecast, #immunotherapy, #inhiibitor, #juergens, #kras, #mcmaster, #mek, #mutation, #rosalyn, #selumetinib, #therapy, #university, #vaccine